Partners
Organisations who have participated in, contributed to, or supported the development, evaluation or deployment of Sensabues’ EB technology.
Anti-Doping:
- Partnership for Clean Competition, USA.
- German Sport University Cologne, Institute of Biochemistry, Centre for Preventive Doping Research, Germany.
- Sportradar, USA.
Drugs of Abuse:
- RCU Labs, California. Recent-use test for cannabis.
- Karolinska Institute, Sweden.
- Karolinska University Hospital, Sweden.
- National Institute of Drug Abuse (NIDA), USA.
- UCSD, UC Center for Medicinal Cannabis Research, USA.
- Ghent University Hospital, Department of Laboratory Medicine, Belgium.
- X-Pertise Consulting, France.
- Beijing Tongren Hospital, China.
- Västerås Hospital, Sweden.
- Swedish Prison and Probation Service, Sweden.
- Västervik Prison, Sweden.
- LKAB, international mining and minerals conglomerate, Sweden.
- SSAB, global steel producer, Sweden.
Therapeutic Drugs:
- University of Liverpool, Institute of Translational Medicine, Liverpool Bioanalytical Facility, UK.
- Ghent University Hospital, Department of Laboratory Medicine, Belgium.
- Jena University Hospital, Department of Clinical Chemistry and Laboratory Medicine, Germany.
Biomarkers and Metabolomics:
- UCSD, USA.
- ABF Labs, Germany.
- CB Med, Center for Biomarker Research in Medicine, Austria.
- CEA Grenoble, Nanosafety Platform, Medical Biology Laboratory, France.
- Karolinska University Hospital, Sweden.
- University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences
- Jinan University, Institute of Atmospheric Environmental Safety and Pollution Control, China.
SARS-CoV-2:
- Pharmaceutical Institute, Kiel University, Germany